Literature DB >> 25440573

Ambulatory vs office blood pressure monitoring in renal transplant recipients.

Jafar Ahmed1, Valerie Ozorio, Maritza Farrant, Walter Van Der Merwe.   

Abstract

Hypertension is common following renal transplantation and has adverse effects on cardiovascular and graft health. Ambulatory blood pressure monitoring (ABPM) is better at overall blood pressure (BP) assessment and is necessary to diagnose nocturnal hypertension, which is also implicated in poor outcomes. The authors performed a retrospective analysis of 98 renal transplant recipients (RTRs) and compared office BP and ambulatory BP recordings. ABPM revealed discordance between office BP and ambulatory BP in 61% of patients, with 3% caused by white-coat and 58% caused by masked hypertension (of which 33% were caused by isolated nocturnal hypertension). Overall, mean systolic BP was 3.6 mm Hg (0.5-6.5) and diastolic BP was 7.5 mm Hg (5.7-9.3) higher via ambulatory BP than office BP. This was independent of estimated glomerular filtration rate, proteinuria, transplant time/type, and comorbidities. A total of 42% of patients had their management changed after results from ABPM. ABPM should be routinely offered as part of hypertension management in RTRs.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25440573      PMCID: PMC8031553          DOI: 10.1111/jch.12448

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

2.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

3.  Ambulatory blood pressure monitoring in kidney transplant patients: RETENAL study.

Authors:  G Fernandez Fresnedo; A Franco Esteve; E Gómez Huertas; V Cabello Chaves; J M Díz Gómez; J M Osorio Moratalla; R Gallego Samper; E Gallego Valcárcel; J M Campistol Plana; R Marín Iranzo; M Arias Rodríguez
Journal:  Transplant Proc       Date:  2012-11       Impact factor: 1.066

4.  Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients.

Authors:  Ali A Haydar; Adrian Covic; Satish Jayawardene; Mohsen Agharazii; Eilish Smith; Isabel Gordon; Helen O'Sullivan; David J A Goldsmith
Journal:  Transplantation       Date:  2004-03-27       Impact factor: 4.939

5.  Evaluating the utility of ambulatory blood pressure monitoring in kidney transplant recipients.

Authors:  Kevin C Wen; Sita Gourishankar
Journal:  Clin Transplant       Date:  2012 Sep-Oct       Impact factor: 2.863

6.  Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients?

Authors:  Adrian Covic; Liviu Segall; David J A Goldsmith
Journal:  Transplantation       Date:  2003-12-15       Impact factor: 4.939

7.  BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial.

Authors:  Myra A Carpenter; Alin John; Matthew R Weir; Stephen R Smith; Lawrence Hunsicker; Bertram L Kasiske; John W Kusek; Andrew Bostom; Anastasia Ivanova; Andrew S Levey; Scott Solomon; Todd Pesavento; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2014-03-13       Impact factor: 10.121

8.  Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring.

Authors:  Ernesto Paoletti; Maurizio Gherzi; Marco Amidone; Fabio Massarino; Giuseppe Cannella
Journal:  Transplantation       Date:  2009-06-27       Impact factor: 4.939

9.  Why automated office blood pressure should now replace the mercury sphygmomanometer.

Authors:  Martin G Myers
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-07-01       Impact factor: 3.738

Review 10.  Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review.

Authors:  J Hodgkinson; J Mant; U Martin; B Guo; F D R Hobbs; J J Deeks; C Heneghan; N Roberts; R J McManus
Journal:  BMJ       Date:  2011-06-24
View more
  15 in total

1.  Use of ambulatory blood pressure monitoring in kidney transplant recipients.

Authors:  Adrian M Whelan; Elaine Ku
Journal:  Nephrol Dial Transplant       Date:  2019-09-01       Impact factor: 5.992

Review 2.  The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.

Authors:  Beje Thomas; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

3.  Sustainability of improvements in medication adherence through a mobile health intervention.

Authors:  John W McGillicuddy; David J Taber; Martina Mueller; Sachin Patel; Prabhakar K Baliga; Kenneth D Chavin; Luke Sox; April P Favela; Brenda M Brunner-Jackson; Frank A Treiber
Journal:  Prog Transplant       Date:  2015-09       Impact factor: 1.187

4.  Ambulatory Blood Pressure Monitoring and Echocardiographic Findings in Renal Transplant Recipients.

Authors:  Ozlem Kendirlinan Demirkol; Meric Oruc; Baris Ikitimur; Sevgi Ozcan; Sibel Gulcicek; Hikmet Soylu; Sinan Trabulus; Mehmet Riza Altiparmak; Nurhan Seyahi
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-22       Impact factor: 3.738

5.  Ambulatory vs office blood pressure monitoring in renal transplant recipients.

Authors:  Jafar Ahmed; Valerie Ozorio; Maritza Farrant; Walter Van Der Merwe
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-29       Impact factor: 3.738

Review 6.  Approach and Management of Hypertension After Kidney Transplantation.

Authors:  Ekamol Tantisattamo; Miklos Z Molnar; Bing T Ho; Uttam G Reddy; Donald C Dafoe; Hirohito Ichii; Antoney J Ferrey; Ramy M Hanna; Kamyar Kalantar-Zadeh; Alpesh Amin
Journal:  Front Med (Lausanne)       Date:  2020-06-16

7.  Ambulatory monitoring unmasks hypertension among kidney transplant patients: single center experience and review of the literature.

Authors:  Eitan Gluskin; Keren Tzukert; Irit Mor-Yosef Levi; Olga Gotsman; Itamar Sagiv; Roy Abel; Aharon Bloch; Dvorah Rubinger; Michal Aharon; Michal Dranitzki Elhalel; Iddo Z Ben-Dov
Journal:  BMC Nephrol       Date:  2019-07-27       Impact factor: 2.388

8.  Sleep-Disordered Breathing and 24-Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study.

Authors:  Francesca Mallamaci; Rocco Tripepi; Graziella D'Arrigo; Vincenzo Panuccio; Giovanna Parlongo; Graziella Caridi; Maria Carmela Versace; Gianfranco Parati; Giovanni Tripepi; Carmine Zoccali
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

9.  Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis.

Authors:  Anna Pisano; Francesca Mallamaci; Graziella D'Arrigo; Davide Bolignano; Gregoire Wuerzner; Alberto Ortiz; Michel Burnier; Nada Kanaan; Pantelis Sarafidis; Alexandre Persu; Charles J Ferro; Charalampos Loutradis; Ioannis N Boletis; Gérard London; Jean-Michel Halimi; Bénédicte Sautenet; Patrick Rossignol; Liffert Vogt; Carmine Zoccali
Journal:  Clin Kidney J       Date:  2021-09-23

10.  Comparing differences and correlation between 24-hour ambulatory blood pressure and office blood pressure monitoring in patients with untreated hypertension.

Authors:  Zhenhong Zhang; Shunyin Wang; Junru Yan; Zhiwen Xu; Dongliang Liang; Baohua Liu; Junjie Liang; Mingjie Chen
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.